MedPath

JNTX-102

Generic Name
JNTX-102

IVIG (Gamunex-C) Treatment Study for POTS Subjects

Phase 1
Completed
Conditions
Postural Tachycardia Syndrome
Interventions
First Posted Date
2019-04-18
Last Posted Date
2024-03-26
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
30
Registration Number
NCT03919773
Locations
🇺🇸

UT Southwestern Medical Center, Dallas, Texas, United States

ALBumin Italian Outcome Septic Shock-BALANCED Trial (ALBIOSS-BALANCED)

Phase 3
Completed
Conditions
Septic Shock
Interventions
Other: Balanced
First Posted Date
2018-08-31
Last Posted Date
2025-03-05
Lead Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Target Recruit Count
1319
Registration Number
NCT03654001
Locations
🇮🇹

Ospedali Riuniti di Ancona, Ancona, AN, Italy

🇮🇹

AOU Policlinico di Bari, Bari, BA, Italy

🇮🇹

ASST Papa Giovanni XXIII, Bergamo, BG, Italy

and more 34 locations

Importance of the Infusion Rate for the Plasma Expanding Effect of 5% Albumin in the Septic Patient

Phase 4
Conditions
Sepsis
Interventions
First Posted Date
2017-05-15
Last Posted Date
2017-05-15
Lead Sponsor
Hainan People's Hospital
Target Recruit Count
60
Registration Number
NCT03153306
Locations
🇨🇳

Hainan Provincial People'S Hospital, Haikou, Hainan, China

Efficacy and Safety of Terlipressin With Albumin Versus Midodrine With Albumin Versus Albumin Alone in Prevention of Paracentesis Induced Circulatory Dysfunction in Cirrhosis

Not Applicable
Completed
Conditions
Cirrhosis
Interventions
First Posted Date
2017-05-09
Last Posted Date
2018-09-05
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
150
Registration Number
NCT03144713
Locations
🇮🇳

Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in Children

Phase 4
Withdrawn
Conditions
Staphylococcal Infection
Streptococcal Infection
Interventions
First Posted Date
2016-09-14
Last Posted Date
2021-05-03
Lead Sponsor
Hospices Civils de Lyon
Registration Number
NCT02899702
Locations
🇫🇷

Hôpital Femme Mère Enfant, Bron, France

Albumin Administration and Outcomes in Cardiac Surgery

Completed
Conditions
Thoracic Surgery
Interventions
First Posted Date
2016-08-25
Last Posted Date
2016-08-25
Lead Sponsor
Vanderbilt University
Target Recruit Count
6249
Registration Number
NCT02878733

Effects of Fluid Balance Control in Critically Ill Patients

Not Applicable
Completed
Conditions
Fluid Shifts
Critical Care
Interventions
Drug: diuretics
Other: fluid restriction
Device: renal replacement
First Posted Date
2016-05-06
Last Posted Date
2020-09-22
Lead Sponsor
Central Hospital, Nancy, France
Target Recruit Count
1411
Registration Number
NCT02765009
Locations
🇫🇷

Centre Hospitalier Régional, Thionville, France

🇫🇷

Centre Hospitalier Régional et Universitaire, Strasbourg, France

🇫🇷

Hopital Nord Franche-Comté, Belfort, France

and more 5 locations

Comparison of Standard Dose Versus Once a Day Intravenous Albumin in Spontaneous Bacterial Peritonitis

Not Applicable
Completed
Conditions
Cirrhosis
Interventions
First Posted Date
2016-04-29
Last Posted Date
2016-04-29
Lead Sponsor
All India Institute of Medical Sciences, New Delhi
Target Recruit Count
40
Registration Number
NCT02756741

Albumin vs. Plasma for PEdiAtric pRiming Trial

Phase 4
Completed
Conditions
Hemorrhage
Interventions
Biological: Fresh Frozen Plasma
First Posted Date
2016-04-14
Last Posted Date
2016-08-30
Lead Sponsor
IRCCS Policlinico S. Donato
Target Recruit Count
80
Registration Number
NCT02738190
Locations
🇮🇹

IRCCS San Donato, San Donato Milanese, MI, Italy

To Compare the Efficacy of Carbepenem Versus Carbepenem Plus GM-CSF in Difficult To Treat Spontaneous Bacterial Peritonitis

Not Applicable
Completed
Conditions
Spontaneous Bacterial Peritonitis
Interventions
Drug: Carbepenem
Drug: GMCSF (of Granulocyte-Monocyte Colony-Stimulating Factor) .
First Posted Date
2015-06-10
Last Posted Date
2017-11-06
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
146
Registration Number
NCT02468089
Locations
🇮🇳

Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

© Copyright 2025. All Rights Reserved by MedPath